(Q38206795)

English

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

scientific article published on 25 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

rhinoconjunctivitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Giorgio Walter Canonica

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Nikolaos G Papadopoulos

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Pablo Rodríguez del Río

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Stephen R Durham

7

object named as

S R Durham

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

object named as

J Bousquet

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1

object named as

O Pfaar

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

P Demoly

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

R Gerth van Wijk

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

L Jacobsen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

H J Malling

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

R Mösges

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

S Rak

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

E Valovirta

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

U Wahn

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M A Calderon

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

European Academy of Allergy and Clinical Immunology

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

25 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

854-867

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

An introduction to patient decision aids

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Measuring quality of life in children with rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Interpretation of rhinoconjunctivitis quality of life questionnaire data

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The visual analogue scale: its use in pain measurement.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Control of allergic rhinitis and asthma test--a formal approach to the development of a measuring tool.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The precision of the conjunctival provocation test

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The chronic care model and diabetes management in US primary care settings: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Unmet needs in severe chronic upper airway disease (SCUAD).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Prospective validation of the "rhino conjunctivitis allergy-control-SCORE©" (RC-ACS©).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of disease control in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38206795&oldid=2160891795"